Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02854540 · ClinicalTrials.gov registry record · NA
Management of Palmar Hyperhidrosis With Hydrogel-based Iontophoresis
A NA study, sponsored by Stanford University.
- Completed
- Registry status
- NA
- Development phase
- 13
- Enrollment target
NCT02854540: Completed NA study, sponsored by Stanford University.
NCT02854540 is a NA study that has completed, run by Stanford University. The registered enrollment target is 13 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02854540, a NA study, has completed, sponsored by Stanford University.
- COMPLETED
- Registry status
- NA
- Development phase
- 13 participants
- Enrollment target
Study Summary
This study will evaluate the use of hydrogel electrode pads (rather than tap water baths) to deliver iontophoresis treatment using a traditional iontophoresis device. Participants will treat one hand with the hydrogel-based iontophoresis device and leave the other hand untreated.
Primary Outcome
Quantification of sweat production measured quantitatively using gravimetry, reported as milligrams of sweat per minute.
Interventions
- DEVICE Hydrogel electrode-based iontophoresis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 13 participants |
| Start Date | 2016-08 |
| Est. Completion | 2018-08-30 |
| Phase | NA |
What the finished NCT02854540 record still lists
NCT02854540 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 13 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 1 intervention - of which Hydrogel electrode-based iontophoresis is the first listed.
NCT02854540 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02854540 about?
NCT02854540 is a clinical study titled "Management of Palmar Hyperhidrosis With Hydrogel-based Iontophoresis". This study will evaluate the use of hydrogel electrode pads (rather than tap water baths) to deliver iontophoresis treatment using a traditional iontophoresis device. Participants will treat one hand with the hydrogel-based iontophoresis device and leave the other hand untreated.
What is the current status of trial NCT02854540?
This trial is currently completed. It is a NA study. The enrollment target is 13 participants. The study started on 2016-08. Estimated completion is 2018-08-30.
What interventions are being tested in trial NCT02854540?
The interventions under investigation include: Hydrogel electrode-based iontophoresis (DEVICE).
Who is sponsoring clinical trial NCT02854540?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02854540's enrollment target sits among peer trials
13 1911th of 2000 higher than 88 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03125655 · 13 participants
Regulation of Inflammatory Genes in Psoriasis
- NCT03774446 · 13 participants · Phase 2
Multicenter Study of Seliciclib (R-roscovitine) for Cushing Disease
- NCT03830151 · 13 participants · Phase 1
Hyperpolarized Carbon C 13 Pyruvate in Diagnosing Glioma in Patients With Brain Tumors
- NCT04573231 · 13 participants · Phase 2
Evaluation of PSMA in HER2- AR+ Metastatic Breast Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia